Tomas Thiel | Karolinska Institutet

Publications
CV
Public outreach and news

Articles

Article: WORLD JOURNAL OF UROLOGY. 2019;37(1):155-163
Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer
Thiel T; Ryk C; Renstrom-Koskela L; Steineck G; Schumacher MC; Wiklund NP; de Verdier PJ
Article: REDOX BIOLOGY. 2015;6:272-277
Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes
Ryk C; Koskela LR; Thiel T; Wiklund NP; Steineck G; Schumacher MC; de Verdier PJ
Article: CANCER LETTERS. 2014;348(1-2):119-125
Secondary stimulation from Bacillus Calmette-Guerin induced macrophages induce nitric oxide independent cell-death in bladder cancer cells
Thiel T; Ryk C; Chatzakos V; Grufman KH; Bavand-Chobot N; Flygare J; Wiklund NP; de Verdier PJ
Article: JOURNAL OF UROLOGY. 2008;180(2):737-741
Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis
Koskela LR; Thiel T; Ehren I; De Verdier PJ; Wiklund NP

All other publications

Thesis / dissertation: 2019
Effects of BCG-treatment on urinary bladder cancer with focus on nitric oxide
Thiel, Tomas

Employments

Affiliated to Research, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 2023-2026

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Molecular Medicine and Surgery, Karolinska Institutet, 2019
University Medical Degree, Karolinska Institutet, 2002

News from KI

Events from KI